GW&K Investment Management LLC Sells 2,531 Shares of Integer Holdings Corporation (NYSE:ITGR)

GW&K Investment Management LLC cut its position in shares of Integer Holdings Corporation (NYSE:ITGR - Free Report) by 0.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 431,000 shares of the medical equipment provider's stock after selling 2,531 shares during the period. GW&K Investment Management LLC owned 1.24% of Integer worth $50,862,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of ITGR. Lee Danner & Bass Inc. bought a new stake in shares of Integer during the 4th quarter worth about $27,000. AdvisorNet Financial Inc bought a new stake in Integer in the 1st quarter valued at about $28,000. Opal Wealth Advisors LLC bought a new stake in shares of Integer during the 1st quarter worth approximately $28,000. Bessemer Group Inc. increased its position in Integer by 73.1% during the 1st quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider's stock worth $35,000 after purchasing an additional 125 shares in the last quarter. Finally, Sterling Capital Management LLC increased its position in Integer by 472.9% during the 4th quarter. Sterling Capital Management LLC now owns 338 shares of the medical equipment provider's stock worth $45,000 after purchasing an additional 279 shares in the last quarter. Institutional investors own 99.29% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the stock. Citigroup upgraded shares of Integer from a "hold" rating to a "strong-buy" rating and upped their price objective for the stock from $133.00 to $140.00 in a research report on Thursday, May 22nd. Raymond James Financial upped their price objective on shares of Integer from $145.00 to $150.00 and gave the stock an "outperform" rating in a research report on Friday, April 25th. Benchmark lowered their price objective on shares of Integer from $150.00 to $140.00 and set a "buy" rating for the company in a research report on Friday, April 25th. Truist Financial set a $150.00 price target on shares of Integer and gave the company a "buy" rating in a research report on Friday, April 25th. Finally, KeyCorp decreased their price target on shares of Integer from $154.00 to $145.00 and set an "overweight" rating for the company in a research report on Monday, April 21st. Two research analysts have rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $146.25.

Integer Trading Down 7.9%

Shares of ITGR traded down $9.14 during trading hours on Thursday, hitting $106.63. 587,564 shares of the stock were exchanged, compared to its average volume of 491,878. The company has a debt-to-equity ratio of 0.78, a current ratio of 3.40 and a quick ratio of 2.14. The firm has a market capitalization of $3.72 billion, a P/E ratio of 50.80, a price-to-earnings-growth ratio of 0.98 and a beta of 0.98. The business has a 50-day moving average of $119.27 and a 200-day moving average of $124.06. Integer Holdings Corporation has a fifty-two week low of $104.93 and a fifty-two week high of $146.36.

Integer (NYSE:ITGR - Get Free Report) last posted its quarterly earnings results on Thursday, July 24th. The medical equipment provider reported $1.55 EPS for the quarter, missing analysts' consensus estimates of $1.57 by ($0.02). Integer had a return on equity of 11.95% and a net margin of 4.38%. Integer's revenue for the quarter was up 11.4% on a year-over-year basis. During the same quarter last year, the firm earned $1.30 earnings per share. On average, research analysts expect that Integer Holdings Corporation will post 6.01 EPS for the current year.

Insider Activity at Integer

In related news, Director Donald J. Spence sold 14,739 shares of the firm's stock in a transaction dated Wednesday, June 4th. The shares were sold at an average price of $120.38, for a total transaction of $1,774,280.82. Following the transaction, the director directly owned 18,781 shares of the company's stock, valued at $2,260,856.78. This trade represents a 43.97% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Martin C. Maxwell sold 8,720 shares of Integer stock in a transaction dated Thursday, June 5th. The stock was sold at an average price of $120.56, for a total transaction of $1,051,283.20. Following the completion of the sale, the director directly owned 22,170 shares in the company, valued at approximately $2,672,815.20. This represents a 28.23% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 362,434 shares of company stock valued at $44,577,115 over the last ninety days. Corporate insiders own 2.16% of the company's stock.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.